KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 89 filers reported holding KEROS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,014 | -5.9% | 299,000 | 0.0% | 0.14% | -24.6% |
| Q1 2023 | $12,767 | -11.1% | 299,000 | 0.0% | 0.19% | -11.2% |
| Q4 2022 | $14,358 | -99.9% | 299,000 | 0.0% | 0.22% | +39.6% |
| Q3 2022 | $11,248,000 | +36.2% | 299,000 | 0.0% | 0.15% | +40.0% |
| Q2 2022 | $8,261,000 | -52.5% | 299,000 | -6.6% | 0.11% | -40.2% |
| Q1 2022 | $17,402,000 | -7.1% | 320,000 | 0.0% | 0.18% | -9.4% |
| Q4 2021 | $18,723,000 | +52.1% | 320,000 | +2.8% | 0.20% | +44.0% |
| Q3 2021 | $12,309,000 | -9.4% | 311,135 | -2.8% | 0.14% | -9.0% |
| Q2 2021 | $13,590,000 | -31.0% | 320,000 | 0.0% | 0.16% | -32.0% |
| Q1 2021 | $19,696,000 | -6.6% | 320,000 | 0.0% | 0.23% | -20.6% |
| Q4 2020 | $21,090,000 | – | 320,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |